Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Volume: 42, Pages: 102180 - 102180
Published: Jul 1, 2020
Abstract
Fingolimod is used for immune therapy in patients with multiple sclerosis. Long-term treatment is associated with a small increase in the risk of herpes virus reactivation and respiratory tract infections. Patients with coronavirus disease 2019 (COVID-19) under Fingolimod treatment have not been described.We report a 57-year old female patient with a relapsing remitting multiple sclerosis under fingolimod treatment who experienced a severe...
Paper Details
Title
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Published Date
Jul 1, 2020
Volume
42
Pages
102180 - 102180
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History